Zelira Therapeutics Statistics
Total Valuation
ZLDAF has a market cap or net worth of 2.90 million. The enterprise value is 7.19 million.
| Market Cap | 2.90M |
| Enterprise Value | 7.19M |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 6.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 114.62 |
| PB Ratio | -0.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.40 |
| EV / Sales | 274.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -92.11% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 52.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.52% in the last 52 weeks. The beta is 0.61, so ZLDAF's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -43.52% |
| 50-Day Moving Average | 0.51 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 39.52 |
| Average Volume (20 Days) | 1,508 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ZLDAF had revenue of 25,301 and -3.00 million in losses. Loss per share was -0.26.
| Revenue | 25,301 |
| Gross Profit | -101,963 |
| Operating Income | -2.56M |
| Pretax Income | -3.03M |
| Net Income | -3.00M |
| EBITDA | -2.46M |
| EBIT | -2.56M |
| Loss Per Share | -0.26 |
Balance Sheet
The company has 23,633 in cash and 3.90 million in debt, giving a net cash position of -3.88 million.
| Cash & Cash Equivalents | 23,633 |
| Total Debt | 3.90M |
| Net Cash | -3.88M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.94M |
| Book Value Per Share | -0.46 |
| Working Capital | -5.39M |
Cash Flow
| Operating Cash Flow | -3.27M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -10,120.40% |
| Pretax Margin | -11,988.78% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZLDAF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.60% |
| Shareholder Yield | -3.60% |
| Earnings Yield | -103.39% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on April 14, 2022. It was a reverse split with a ratio of 0.0057143.
| Last Split Date | Apr 14, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0057143 |
Scores
ZLDAF has an Altman Z-Score of -58.79. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -58.79 |
| Piotroski F-Score | n/a |